From The Guardian: “UK regulators have given the go-ahead for the first clinical trial of the use of the psychedelic drug dimethyltriptamine (DMT) to treat depression. The trial will initially give the drug – known as the “spirit molecule” for the powerful hallucinogenic trips it induces – to healthy individuals, but it is expected to be followed by a second trial in patients with depression, where DMT will be given alongside psychotherapy…”
Read More“Psychedelics have been a mainstay for a millennia and appreciated in the counter-culture for decades. In 2020, whether consuming, investing, or both, mushrooms are having a moment…”
Read More“Ross and Dwyer are at the centre of the country's first clinical trial of psychedelic drugs for treating severe depression in the terminally ill. Within a month, they will begin recruiting 40 depressed and incurable patients in an attempt to relieve their distress with a novel treatment: between one and two 25-milligram doses of synthetic psilocybin, the psychedelic ingredient found in "magic mushrooms", accompanied by intensive psychotherapy sessions…”
Read More“As a constable with the Ontario Provincial Police, Matt Chorny regularly responded to car accidents. He often dealt with victims and family members throughout the entire process, from the crash to the morgue. Over time, such incidents took an emotional toll. These days, he’s coping with the help of a surprising source — ayahuasca…”
Read More“After Denver paved the way by decriminalizing mushrooms, a major city in California is moving on other psychedelics like ayahuasca, ibogaine, and mescaline cacti. Now Oakland is calling for decriminalization of other psychedelics like mescaline cacti, ayahuasca and ibogaine…”
Read More“A milky, psychoactive secretion that oozes from the glands of a North American toad could provide a fast-acting and extremely potent treatment for depression, according to a new study. The amphibian in question is the Colorado river toad, or Bufo alvarius…”
Read More“The first formal centre for psychedelic research in the world will launch at Imperial College London today. Funded by more than £3 million from five founding donors, the new Imperial Centre for Psychedelic Research will build on over a decade of pioneering work in this area carried out at Imperial, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression…”
Read More“Though psychedelic drugs remain illegal, guided ceremonies, or sessions, are happening across the country, as more Americans seek out safe, structured environments to use psychedelics for spiritual growth and psychological healing. This new world of psychedelic-assisted therapy functions as a kind of parallel mental health service…”
Read MoreSo, what about using ancient plant medicines to treat addiction? It may seem completely contradictory to treat someone who has a substance use disorder with a psychedelic drug that may induce hallucinations, but there's emerging evidence to support this approach…
Read MoreSome of Silicon Valley’s most prominent investors are betting that the eventual legalisation of psychedelics could create the next big frontier in the mental health industry. For instance, Peter Thiel is behind one company, Compass, that has reportedly already made tens of thousands of doses of the active ingredient in magic mushrooms, Psilocybin, for the treatment of depression…
Read Morepsychedelic.support is a website that will showcase clinics and providers who are looking to network with one another and connect with people seeking treatment. This site could soon become a useful asset to anyone interested in the professional world of psychedelic-related therapy… Continue reading
Read MoreThere has been a boom in interest in psychedelics, though many people, including licensed providers (LPs), are unfamiliar with the applicable laws and grey areas. Researchers, and advocates must grapple with how to address psychedelics in a way that does not reinforce the harms and injustices of the War on Drugs. We believe the harm reduction movement has much to offer to those who are interested in the current “Psychedelic Renaissance.”…
Read More
